Family Medicine · Hazle Township, PA
NPI
1639141492
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
420 W 23rd St
Hazle Township, PA, 18202
Phone (570) 455-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
5,356 services
Medicare patients, 2024
577
Average age 79
Drug cost, 2024
$2.0M
27,484 prescriptions
Company payments, 2024
$45.93
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark J Lobitz was code J1010 (injection, methylprednisolone acetate, 1 mg), 760 times for 21 patients. In total Mark J Lobitz billed 5,356 services in 55 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 760 | 21 | $0.10 | $75.86 |
| 99214 Office E&M - Established | Office | 688 | 335 | $76.16 | $52K |
| 99308 SNF E&M | Office | 660 | 151 | $51.88 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 333 | 227 | $11.03 | $3,674 |
| 99497 Care Management/Coordination | Office | 291 | 282 | $71.05 | $21K |
| 99309 SNF E&M | Office | 291 | 110 | $74.85 | $22K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 213 | 213 | $117.67 | $25K |
| 99213 Office E&M - Established | Office | 185 | 136 | $48.82 | $9,031 |
| 99308 SNF E&M | Facility | 185 | 87 | $53.45 | $9,888 |
| 83036 Blood Count | Office | 169 | 101 | $9.46 | $1,599 |
| G0008 Administration of influenza virus vaccine | Office | 158 | 158 | $30.77 | $4,862 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 119 | 40 | $0.87 | $104 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 117 | 117 | $16.92 | $1,979 |
| 96372 Injection Administration | Office | 108 | 33 | $9.17 | $990 |
| 90662 Vaccine Product | Office | 101 | 101 | $81.82 | $8,264 |
By year: 2022 $298K for 5,586 services; 2023 $298K for 5,235 services; 2024 $245K for 5,356 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 169 | 101 | $9.46 | $1,599 |
| 82570 Clinical Chemistry | 29 | 28 | $5.08 | $147 |
| 82043 Clinical Chemistry | 26 | 25 | $5.44 | $142 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark J Lobitz prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,589 prescriptions and refills. In total Mark J Lobitz wrote 27,484 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,589 | 2,552 | 248 | $20K |
| Levothyroxine Sodium Generic | 1,203 | 1,808 | 166 | $12K |
| Amlodipine Besylate Generic | 1,123 | 1,726 | 167 | $9,111 |
| Eliquis Apixaban | 1,008 | 1,050 | 78 | $327K |
| Lisinopril Generic | 792 | 1,278 | 131 | $6,192 |
| Metoprolol Tartrate Generic | 771 | 947 | 89 | $6,225 |
| Losartan Potassium Generic | 720 | 1,135 | 120 | $11K |
| Metoprolol Succinate Generic | 702 | 1,026 | 93 | $12K |
| Sertraline Hcl Generic | 655 | 799 | 89 | $7,093 |
| Gabapentin Generic | 601 | 673 | 73 | $7,215 |
| Pantoprazole Sodium Generic | 595 | 811 | 95 | $9,766 |
| Metformin Hcl Generic | 554 | 850 | 82 | $3,886 |
| Omeprazole Generic | 541 | 897 | 116 | $8,063 |
| Furosemide Generic | 505 | 600 | 100 | $2,721 |
| Potassium Chloride Generic | 474 | 569 | 78 | $9,718 |
Brand drugs: 4,654 claims; generic drugs: 22,762 claims; opioid claims: 135.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark J Lobitz $45.93 ($45.93 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $28.22.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.